SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

WILMETTE, Ill., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) NASDAQ:MNPR, a clinical—stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced third quarter 2026 financial results and provided…

MNPR
SquawkNews Desk

Related stories

AAON Expands Credit Facility to Up to $1.2 Billion AAON said it refinanced and expanded its credit facility to up to $1.2 billion. M impact | EQUITY | Nov 12, 2026, 03:11 PM UTC Hyperliquid Nvidia Perpetual Futures Reach Nearly $2 Billion in 24-Hour Volume The Nvidia-linked contract ranked second on Hyperliquid, behind Bitcoin perpetual futures. M impact | EQUITY | Nov 12, 2026, 03:10 PM UTC Page Industries Shares Plunge 13% as Higher Raw-Material Costs Hit Q2 Profitability Page Industries shares fell 13% to Rs. 31,850, their lowest level since April, as investors reacted to second-quarter profitability pressure from higher raw-material costs. M impact | EQUITY | Nov 12, 2026, 03:09 PM UTC Maersk Opens Montevideo Logistics Facility With Investment Above USD 20 Million Maersk opened a logistics facility in Montevideo, investing more than USD 20 million. M impact | EQUITY | Nov 12, 2026, 03:07 PM UTC US Neocloud Stocks Fall Up to 16% After Huang Resigns as Nvidia CEO Nebius led losses in early US trading as investors assessed the implications of Jensen Huang's resignation from Nvidia. M impact | EQUITY | Nov 12, 2026, 03:06 PM UTC Southern Company Announces $1.75 Billion Mandatory Convertible Southern Company announced a $1.75 billion mandatory convertible. Its shares edged down. M impact | EQUITY | Nov 12, 2026, 03:05 PM UTC